Notably, the co-expression of granulocyte–macrophage colony-stimulating factor (GM-CSF) and IFN-I within MOC2 tumors accelerated tumor regression, underscoring that IFN-I signaling in cancer cells supported DC function to drive antitumor immunity. Here, CSF2 is linked to cancer.